It has been a tough year for Walgreens Boots Alliance (NASDAQ: WBA) so far, with the stock losing steadily amid muted sales growth and falling margins. The drugstore operator is all set to release its fourth-quarter financial results on Monday before the opening bell.
The consensus earnings estimate for the quarter is $1.41 per share, down 5% from last year. Sales are forecast to rise about 1% $33.89 billion. The bottom-line surpassed estimates in three of the trailing four quarters.
Like in the previous quarters, prescriptions transferred from Rite Aid stores and contributions from the revamped contract with Express Scripts will likely add to sales growth in retail pharmacy, the company’s main operating unit. Initial estimates indicate positive comparable store sales for the August-quarter. These factors might help the pharmacy segment in the US to achieve strong volume growth.
It is estimated that the drug chain’s revised tobacco policy would weigh on overall performance this time, when compared to last year. Earlier this year, the management announced plans to impose curbs on tobacco sales in stores across the country. Also, the decline in store footfall due to the ongoing reorganization may have a negative impact on volumes.
The overseas markets, meanwhile, paint a bleak picture, owing to pricing issues and the general weakness in retail markets, especially in Europe. This will be partially offset by the positive trend in the company’s wholesale business in emerging markets. Going forward, the general uptick in prescription volumes will contribute to sales growth, though there is no clarity with regard to the management’s strategy to revive growth.
For the third quarter, the company reported sales of about $35 billion, which was broadly unchanged from the year-ago period. Earnings, on an adjusted basis, dropped 4% annually to $1.47 per share. The results topped the Street view.
A few months ago, Walgreens shares plunged to a six-year low and maintained the downtrend since then. In the past twelve months, the stock lost about 29%, while the healthcare sector and the general market registered strong growth.
Tyson Foods Inc. (NYSE: TSN) reported first quarter 2023 earnings results today. Sales rose 2.5% year-over-year to $13.2 billion. Net income attributable to Tyson was $316 million, or $0.88 per
Apple Inc. (NASDAQ: AAPL) this week reported its first revenue decline in more than three years, even as the high inflation continues to squeeze customers’ spending power. Sales of the
Chipmaker Qualcomm, Inc. (NASDAQ: QCOM) has reported lower earnings and revenues for the first quarter of 2023. The company also provided guidance for the second quarter of 2023. At $9.5